WO2011085643A8 - 吡啶并环衍生物 - Google Patents
吡啶并环衍生物 Download PDFInfo
- Publication number
- WO2011085643A8 WO2011085643A8 PCT/CN2011/000068 CN2011000068W WO2011085643A8 WO 2011085643 A8 WO2011085643 A8 WO 2011085643A8 CN 2011000068 W CN2011000068 W CN 2011000068W WO 2011085643 A8 WO2011085643 A8 WO 2011085643A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pyridine derivatives
- fused pyridine
- disclosed
- formula
- noninsulin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/522,304 US8680089B2 (en) | 2010-01-15 | 2011-01-17 | Fused pyridine derivatives |
EP11732633.0A EP2524917B1 (en) | 2010-01-15 | 2011-01-17 | Fused pyridine derivatives |
CN201180006084.4A CN102741251B (zh) | 2010-01-15 | 2011-01-17 | 吡啶并环衍生物 |
JP2012548326A JP5719382B2 (ja) | 2010-01-15 | 2011-01-17 | 縮環ピリジン誘導体 |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010011869.8 | 2010-01-15 | ||
CN201010011869 | 2010-01-15 | ||
CN2010101754046A CN102127070A (zh) | 2010-01-15 | 2010-04-29 | 吡啶并环衍生物 |
CN201010175404.6 | 2010-04-29 | ||
CN201010230754.8 | 2010-07-10 | ||
CN2010102307548A CN102127071A (zh) | 2010-01-15 | 2010-07-10 | 吡啶并环衍生物 |
CN201010291056.9 | 2010-09-17 | ||
CN2010102910569A CN102127072A (zh) | 2010-01-15 | 2010-09-17 | 吡啶并环衍生物 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011085643A1 WO2011085643A1 (zh) | 2011-07-21 |
WO2011085643A8 true WO2011085643A8 (zh) | 2012-07-05 |
Family
ID=44265377
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2011/000068 WO2011085643A1 (zh) | 2010-01-15 | 2011-01-17 | 吡啶并环衍生物 |
Country Status (5)
Country | Link |
---|---|
US (1) | US8680089B2 (zh) |
EP (1) | EP2524917B1 (zh) |
JP (1) | JP5719382B2 (zh) |
CN (4) | CN102127070A (zh) |
WO (1) | WO2011085643A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109219607A (zh) * | 2016-06-08 | 2019-01-15 | 山东轩竹医药科技有限公司 | 二肽基肽酶-iv 抑制剂的丁二酸盐的晶型 |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102127070A (zh) * | 2010-01-15 | 2011-07-20 | 山东轩竹医药科技有限公司 | 吡啶并环衍生物 |
US8927572B2 (en) * | 2011-07-09 | 2015-01-06 | Xuanzhu Pharma Co., Ltd. | Crystal form I of salt of a dipeptidyl peptidase-IV inhibitor and preparation method and use thereof |
US9884822B2 (en) | 2012-02-09 | 2018-02-06 | Arch Chemicals, Inc. | Process for the preparation of 1-hydroxy-6-substituted pyridones |
CN104003934B (zh) * | 2014-06-13 | 2016-04-13 | 西华大学 | 6-氯-3-氟-2-吡啶甲酸的合成 |
GB201516396D0 (en) * | 2015-09-16 | 2015-10-28 | Givaudan Sa | Improvements in or relating to organic compounds |
WO2017107945A1 (zh) * | 2015-12-24 | 2017-06-29 | 山东轩竹医药科技有限公司 | 二肽基肽酶-iv抑制剂的苯甲酸盐的晶型 |
SI3452465T1 (sl) * | 2016-05-04 | 2021-04-30 | Genoscience Pharma | Substituirani derivati 2,4-diamino-kinolina za uporabo v zdravljenju proliferativnih bolezni |
CN106478628B (zh) * | 2016-10-11 | 2018-09-28 | 南阳师范学院 | 一种吡啶并[2’,1’:2,3]哌啶[1,6-a]吡咯盐及其合成方法 |
CN108329330B (zh) * | 2017-01-20 | 2021-05-04 | 复旦大学 | 2-苄氧苯基噁唑并吡啶类化合物及其药物用途 |
CN114349758B (zh) * | 2022-01-21 | 2023-12-15 | 中国药科大学 | 一种母核为吡啶并咪唑的化合物及其制备方法和应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5187159A (en) * | 1991-10-07 | 1993-02-16 | Merck & Co., Inc. | Angiotensin II antagonists incorporating a substituted 1,3-benzodioxole or 1,3-benzodithiole |
NZ540495A (en) * | 2002-12-04 | 2007-09-28 | Eisai R&D Man Co Ltd | 1,3-Dihydro-imidazole fused-ring compound |
RU2007140903A (ru) * | 2005-04-05 | 2009-05-20 | Фармакопия, Инк. (Us) | Производные пурина и имидазопиридина для иммуносупрессии |
UY29823A1 (es) * | 2005-10-03 | 2007-05-31 | Astrazeneca Ab | Derivados sustituidos de 7-cloro-3h-imidazol-(4,5-b) piridina, composiciones farmacéuticas que los contienen, procesos para la preparación de los mismos y aplicaciones |
BRPI0707245A2 (pt) * | 2006-01-23 | 2011-04-26 | Crystalgenomics Inc | derivados de imidazopiridina que inibem a atividade de proteìna quinase, método para a preparação destes e composição farmacêutica contendo os mesmos |
KR20070077468A (ko) * | 2006-01-23 | 2007-07-26 | 크리스탈지노믹스(주) | 단백질 키나아제 활성을 저해하는 이미다조피리딘 유도체,이의 제조방법 및 이를 함유하는 약학 조성물 |
CN101600715A (zh) * | 2006-12-21 | 2009-12-09 | 辉瑞产品公司 | 具有血管紧张素II受体拮抗作用和PPARγ活化活性的化合物 |
ES2303776B1 (es) * | 2006-12-29 | 2009-08-07 | Laboratorios Almirall S.A. | Derivados de 5-fenil-6-piridin-4-il-1,3-dihidro-2h-imidazo(4,5-b)piridin-2-ona utiles como antagonistas del receptor de adenosina a2b. |
CN101397300B (zh) * | 2007-09-04 | 2011-04-27 | 山东轩竹医药科技有限公司 | 二肽酶-ⅳ抑制剂衍生物 |
MX2010008518A (es) * | 2008-02-04 | 2010-11-10 | Cytokinetics Inc | Ciertas entidades quimicas, composiciones y metodos. |
CN102127070A (zh) * | 2010-01-15 | 2011-07-20 | 山东轩竹医药科技有限公司 | 吡啶并环衍生物 |
-
2010
- 2010-04-29 CN CN2010101754046A patent/CN102127070A/zh active Pending
- 2010-07-10 CN CN2010102307548A patent/CN102127071A/zh active Pending
- 2010-09-17 CN CN2010102910569A patent/CN102127072A/zh active Pending
-
2011
- 2011-01-17 JP JP2012548326A patent/JP5719382B2/ja active Active
- 2011-01-17 US US13/522,304 patent/US8680089B2/en active Active
- 2011-01-17 CN CN201180006084.4A patent/CN102741251B/zh active Active
- 2011-01-17 WO PCT/CN2011/000068 patent/WO2011085643A1/zh active Application Filing
- 2011-01-17 EP EP11732633.0A patent/EP2524917B1/en active Active
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109219607A (zh) * | 2016-06-08 | 2019-01-15 | 山东轩竹医药科技有限公司 | 二肽基肽酶-iv 抑制剂的丁二酸盐的晶型 |
CN109219607B (zh) * | 2016-06-08 | 2021-03-30 | 吉林惠升生物制药有限公司 | 二肽基肽酶-iv抑制剂的丁二酸盐的晶型 |
Also Published As
Publication number | Publication date |
---|---|
CN102127070A (zh) | 2011-07-20 |
CN102127071A (zh) | 2011-07-20 |
EP2524917A4 (en) | 2015-03-11 |
EP2524917A1 (en) | 2012-11-21 |
EP2524917B1 (en) | 2018-06-27 |
CN102127072A (zh) | 2011-07-20 |
CN102741251A (zh) | 2012-10-17 |
US20120289497A1 (en) | 2012-11-15 |
CN102741251B (zh) | 2015-03-25 |
JP5719382B2 (ja) | 2015-05-20 |
WO2011085643A1 (zh) | 2011-07-21 |
US8680089B2 (en) | 2014-03-25 |
JP2013517225A (ja) | 2013-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011085643A8 (zh) | 吡啶并环衍生物 | |
MX2011012122A (es) | Derivados de tiofeno. | |
SG155961A1 (en) | Pyrazoles as 11-beta-hsd-1 | |
AU2011274192A8 (en) | Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof | |
WO2008135791A8 (en) | Imidazoquinolines with immuno-modulating properties | |
MX2014004479A (es) | Derivados de oxazina novedosos y su uso en el tratamiento de enfermedades. | |
MY159058A (en) | Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agent | |
NZ608116A (en) | Triazine-oxadiazoles | |
WO2009010416A3 (en) | Inhibitors of 11b-hydroxysteroid dehydrogenase | |
HK1149258A1 (en) | Compounds | |
MX2010009922A (es) | Activadores de piridazinona glucocinasa. | |
WO2010003624A3 (en) | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof | |
WO2009125434A3 (en) | Oxime derivatives, process for their preparation, pharmaceutical composition containing the same and medicinal use thereof | |
MX2009013501A (es) | Compuestos piperidinicos y sus usos. | |
MX2013000474A (es) | Derivados de arilamida novedosos que tienen propiedades antiandrogenicas. | |
WO2014045162A8 (en) | ALKYL-SUBSTITUTED HEXAHYDROPYRANO[3,4-d] [1,3]THIAZIN-2-AMINE COMPOUNDS | |
WO2008006795A3 (en) | Indole compounds | |
TN2009000275A1 (en) | Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome | |
WO2011045232A3 (en) | Neuropeptide-2 receptor (y-2r) agonists | |
WO2010052144A3 (en) | Neuropeptide-2-receptor (y-2r) agonists and uses thereof | |
WO2011097946A8 (zh) | 含有并环稠合双环的噁唑烷酮化合物及其制备和应用 | |
WO2009140341A3 (en) | Atorvastatin compositions | |
WO2008098978A3 (en) | Benzofuran compounds useful in the treatment of conditions mediated by the action of pge2 at the ep1 receptor | |
WO2014201016A3 (en) | Inhibitors of the mitf molecular pathway | |
WO2008035305A8 (en) | Pyridine derivatives for the treatment of metabolic disorders related to insulin resistance or hyperglycemia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201180006084.4 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13522304 Country of ref document: US Ref document number: 2012548326 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011732633 Country of ref document: EP |